Amyloid-β and α-Synuclein Decrease the Level of Metal-Catalyzed Reactive Oxygen Species by Radical Scavenging and...

Area of Science:

• Biochemistry
• Neuroscience
• Oxidative Stress Research

Background:

• Reactive oxygen species (ROS) are implicated in neurodegenerative disease pathogenesis.
• Alzheimer's and Parkinson's diseases are associated with amyloid-beta (Aβ) and alpha-synuclein (αS) protein aggregation, respectively.
• The role of metal ions, such as copper (Cu2+), in ROS generation within these diseases is under investigation.

Purpose of the Study:

• To investigate the effect of soluble and aggregated Aβ and αS on Cu(2+)-catalyzed ROS formation in vitro.
• To elucidate the mechanisms by which these peptides influence ROS generation in the presence of a biological reductant.

Main Methods:

• In vitro study using Cu(2+)-catalyzed reactions.
• Assessing ROS levels and generation rates.
• Utilizing soluble and aggregated forms of amyloid-beta (Aβ) and alpha-synuclein (αS).

Main Results:

• Cu(2+) binding to Aβ and αS significantly reduced ROS levels and generation rates.
• Oligomeric and fibrillar forms of Aβ and αS were particularly effective in reducing ROS.
• Mechanisms proposed include radical scavenging and redox silencing by the peptide-metal complexes.

Conclusions:

• Aggregated Aβ and αS do not appear to be directly ROS-active.
• The observed increase in ROS in neurodegenerative diseases may stem from localized metal ion accumulation within aggregates.
• Amyloid structure formation could indirectly lead to increased oxidative stress as a downstream effect.